Repare Therapeutics Inc. (RPTX) Tops Q2 EPS by 5c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q2 EPS of ($0.82), $0.05 better than the analyst estimate of ($0.87). Revenue for the quarter came in at $1.07 million versus the consensus estimate of $2.58 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results